mdlinx mdlinx

Oncology News Articles

The latest Cancer and Oncology news articles. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the medical articles that will make a difference to you and your practice. Organized by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants can stay current on latest Cancer/Oncology clinical articles.

Hematology exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. Featured are clinical pearls from The Smartest Oncologist to oncology topics from the Smartest Doc daily quiz challenge.

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx
New! >> Find out who is the Smartest Doc in Oncology!

Articles

Latest (96) Full Text Articles (6313) Focus on Neurologic
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

1 Survival of women with inflammatory breast cancer: A large population based study Annals of Oncology, April 16, 2014    Clinical Article

2 Prediction of hepatocellular carcinoma recurrence in patients with low hepatitis B virus DNA levels and high preoperative hepatitis B surface antigen levels JAMA Surgery, April 16, 2014    Clinical Article

3 Cigarette smoking, physical activity, and alcohol consumption as predictors of cancer incidence among women at high risk of breast cancer in the NSABP P-1 trial Cancer Epidemiology, Biomarkers & Prevention, April 16, 2014    Clinical Article

4 MYC protein expression is associated with poor prognosis in diffuse large B cell lymphoma patients treated with RCHOP chemotherapy Tumor Biology, April 16, 2014    Clinical Article

5 Periostin is a new potential prognostic biomarker for glioma Tumor Biology, April 16, 2014    Clinical Article

6 Deficiency in asparagine synthetase expression in rectal cancers receiving concurrent chemoradiotherapy: negative prognostic impact and therapeutic relevance Tumor Biology, April 16, 2014    Clinical Article

7 Serum albumin as a significant prognostic factor in patients with malignant pleural mesothelioma Tumor Biology, April 16, 2014    Clinical Article

8 Eribulin monotherapy in patients aged 70 years and older with metastatic breast cancer Full Text The Oncologist, April 16, 2014    Clinical Article

9 14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphoma Genes, Chromosomes and Cancer, April 16, 2014    Clinical Article

10 Analyzing 395,793 samples shows significant association between rs999737 polymorphism and breast cancer Tumor Biology, April 16, 2014    Clinical Article

11 Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11 Clinical Cancer Research, April 16, 2014    Clinical Article

12 KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild type stage III colon cancers from an adjuvant chemotherapy trial (N0147 Alliance) Clinical Cancer Research, April 16, 2014    Clinical Article

13 Physical activity in relation to risk of hematologic cancers: a systematic review and meta-analysis Cancer Epidemiology, Biomarkers & Prevention, April 16, 2014    Evidence Based Medicine    Review Article

14 Adaptive designs for clinical trials assessing biomarker-guided treatment strategies British Journal of Cancer, April 16, 2014    Clinical Article

15 Changes in intestinal permeability and nutritional status after cytotoxic therapy in patients with cancer Nutrition and Cancer, April 16, 2014    Clinical Article

16 CD19-CAR Trials Full Text The Cancer Journal, April 16, 2014    Clinical Article

17 Sipuleucel-T and immunotherapy in the treatment of prostate cancer Expert Opinion on Biological Therapy, April 16, 2014    Clinical Article

18 Cervical cytology screening among low-income, minority adolescents in New York City following the 2009 ACOG guidelines Preventive Medicine, April 16, 2014    Clinical Article

19 Cholelithiasis and the risk of liver cancer: results from cohort studies of 134 546 Chinese men and women Journal of Epidemiology and Community Health, April 16, 2014    Clinical Article

20 DSE-FRET: A new anticancer drug screening assay for DNA binding proteins Cancer Science, April 16, 2014    Review Article

50 available pages FirstPrevious 1 2 3 4 5 6 7 8 9 10 Next Last

Clinical Pearls in Oncology

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.

Read the article summary

HCC risk increased in patients with AIDS

As reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.

Read the article summary

RAB25 is a prognostic marker for ovarian cancer

As reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Oncology Articles

Last month's top read Top Articles of 2013

1 Coffee intake and gastric cancer risk Cancer Epidemiology, Biomarkers & Prevention, March 20, 2014

2 Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial The Lancet Oncology, March 7, 2014

3 Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial The Lancet Oncology, March 11, 2014

4 Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials The Lancet, March 25, 2014    Evidence Based Medicine

5 Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): A companion analysis of a randomised controlled trial The Lancet Oncology, March 14, 2014

6 Chemoradiation therapy versus chemotherapy alone for gastric cancer after R0 surgical resection: A meta-analysis of randomized trials Oncology, February 4, 2014    Evidence Based Medicine

7 Risk of developing myelodysplastic syndromes in prostate cancer patients definitively treated with radiation Journal of the National Cancer Institute, March 4, 2014

8 Screening for prostate cancer with the prostate-specific antigen test: A review of current evidence JAMA, March 21, 2014    Evidence Based Medicine

9 Dietary carrot consumption and the risk of prostate cancer European Journal of Nutrition, February 17, 2014

10 Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: A meta-analysis of individual patient data The Lancet Oncology, March 7, 2014

11 A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients Annals of Oncology, February 18, 2014

12 Radical prostatectomy or watchful waiting in early prostate cancer New England Journal of Medicine, March 10, 2014    Evidence Based Medicine

13 Coffee consumption and prostate cancer risk: An updated meta-analysis Cancer Causes and Control, March 4, 2014    Evidence Based Medicine

14 Statins and aspirin for chemoprevention in Barrett's esophagus: Results of a cost-effectiveness analysis Cancer Prevention Research, February 25, 2014

15 Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): Follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort The Lancet Oncology, March 24, 2014

16 Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab Journal of Clinical Oncology, March 19, 2014

17 Tea consumption and leukemia risk: A meta-analysis Tumor Biology, February 13, 2014    Evidence Based Medicine

18 Vemurafenib in patients with BRAFV600 mutated metastatic melanoma: an open-label, multicentre, safety study The Lancet Oncology, March 3, 2014

19 Yoga’s impact on inflammation, mood, and fatigue in breast cancer survivors: a randomized controlled trial Journal of Clinical Oncology, February 3, 2014

20 Tumor infiltrating lymphocytes is prognostic and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial Annals of Oncology, March 12, 2014

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore

Other Topics in Oncology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow
Like

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close